Atlas Trials

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.

Clinical trial NCT00174915 · COMPLETED

Trial details

NCT number
NCT00174915
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gout
Start date
2003-02-01
Primary completion
2004-04-01
Enrollment
1072

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.